An investigation for investors in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) shares over potential securities laws violations by Taro Pharmaceutical Industries was announced and NYSE:TARO stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 10/27/2016 --Taro Pharmaceutical Industries Ltd is under investigation over potential securities laws violations. The investigation was announced for investors in NYSE:TARO shares in connection certain financial statements made by Taro Pharmaceutical Industries.

Investors who purchased shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) concerning whether a series of statements by Taro Pharmaceutical Industries regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On September 9, 2016, Taro Pharmaceutical Industries Ltd. disclosed it and two of its senior officers received grand jury subpoenas in connection with a federal antitrust investigation into generic drug pricing. Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) declined from $145.20 per share in August 2016 to as low as $101.02 per share on October 20, 2016.

Those who purchased shares of Taro Pharmaceutical Industries Ltd. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com